Almost no other US exchange-traded fund issuer is experiencing a sharper asset decline than Cathie Wood’s Ark Investment Management this year. Last year, her flagship ARK Innovation ETF lost 23 percent of its value while the S&P 500 increased by 27 percent. Cathie Wood, CEO of ARK Investment Management, claims that her clients trust her approach to investing. Massive stockpiles kept by US corporations, according to Wood, indicate that inflation will slow this month. Earlier in June, the company’s shares had inflows of more than $180 million.
Insider Monkey highlighted the 10 micro-cap stocks to buy according to Cathie Wood. An Israeli high-tech business called Allot Ltd., formerly known as Allot Communications, creates software for telecommunications. In the first three months of 2022 compared to the prior quarter, the fund boosted its holding in the company by 23%. A publicly traded firm called Silicom Ltd. focuses on designing, producing, and marketing connectivity solutions for various servers and server-based applications. At the end of the first quarter of 2022, ARK owned 58,175 Silicom shares, valued at $2.29 million. Networking equipment provider Ceragon Networks Ltd. specializes in wireless point-to-point communication. As of Q1 2022, Cathie Wood owned more than 1.1 million Ceragon Networks shares, valued at $2.37 million. An Israeli business called Enlivex Therapeutics Ltd. is in the trial stages of developing cell immunotherapy. A generic off-the-shelf cell treatment called Allocetra is intended to rewire macrophages to achieve homeostasis. At the conclusion of the first quarter, Cathie Wood owned 333,472 shares of UroGen Pharma Ltd. through ARK Investment Management, valued at $2.9 million. Anita Dushyanth, a Berenberg analyst, began covering Urogen with a Buy rating and a $20 price target. For more details, click 10 Micro-Cap Stocks To Buy According To Cathie Wood.
